Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus Combined With Overweight or Obesity”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Post-approval studies (Phase 4)Active Not RecruitingNCT06860841
What this trial is testing

Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM

Who this might be right for
Type 2 DiabetesOverweight and Obese Adults
Campus Bio-Medico University 16
Early research (Phase 1)Not Yet RecruitingNCT07765511
What this trial is testing

Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 60
Not applicableStudy completedNCT01464073
What this trial is testing

Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat

Who this might be right for
Obesity
Centre Hospitalier Universitaire de la Réunion 137
Testing effectiveness (Phase 2)Looking for participantsNCT07589608
What this trial is testing

Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 400
Early research (Phase 1)Looking for participantsNCT07747857
What this trial is testing

A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

Who this might be right for
Type 2 Diabetes Mellitus Combined With Overweight or Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 72
Testing effectiveness (Phase 2)WithdrawnNCT06901349
What this trial is testing

Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Testing effectiveness (Phase 2)Looking for participantsNCT07215559
What this trial is testing

Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Who this might be right for
ObesityOverweightDiabetes Mellitus, Type 2
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Looking for participantsNCT06924320
What this trial is testing

MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Who this might be right for
Obesity and Obesity-related Medical Conditions
Pfizer 381
Not applicableStudy completedNCT01186952
What this trial is testing

Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes

Who this might be right for
OverweightObesityType 2 Diabetes
Institut de Recherches Cliniques de Montreal 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06151964
What this trial is testing

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Who this might be right for
Overweight and Obesity
AstraZeneca 166
Large-scale testing (Phase 3)Study completedNCT05394519
What this trial is testing

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

Who this might be right for
OverweightObesityType 2 Diabetes Mellitus
Novo Nordisk A/S 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06603571
What this trial is testing

Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 367
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643728
What this trial is testing

Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 252